ASCO: anticoagulant use predicts metastatic prostate CA survival
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to research presented ...
Feb 19, 2013
0
0